Sort by
Intrathecal Morphine Versus Four-Quadrant Transversus Abdominis Plane Blocks in Gynecologic Cancer Surgery: A Single-Center Retrospective Study
Duygu Akyol,
Şerife Özalp,
Funda Gümüş Özcan
Posted: 13 March 2025
The Global Burden of Maxillofacial Trauma in Critical Care: Epidemiology, Prevention, Economics, and Outcomes
Antonino Maniaci,
Mario Lentini,
Luigi Vaira,
Salvatore Lavalle,
Salvatore Ronsivalle,
Francesca Maria Rubulotta,
Lepanto Lentini,
Daniele Salvatore Paternò,
Cosimo Galletti,
Massimiliano Sorbello
Posted: 10 March 2025
ICU ‘Magic Numbers’: The Role of Biomarkers in Supporting Clinical Decision-Making
Francesco Cipulli,
Eleonora Balzani,
Giuseppe Marini,
Sergio Lassola,
Silvia De Rosa,
Giacomo Bellani
Posted: 07 March 2025
Reducing Emergency Department Burden Through the Implementation of Femoral Nerve Block in Patients with Femur Fractures
Kuo-chen Chung,
Chih-Cheng Wu,
Hsiu-E Chen,
Subeq Yi-Maun,
Chia-Hung Yeh,
Shih-Chieh Yang
Posted: 05 March 2025
Perioperative and Anesthetic Considerations for Post-Acute Sequelae of COVID (PASC)/ Long COVID
Ram Yogendra,
Alice Perlowski,
Breeana Johng,
Hazem Dahshan,
Christian Orr,
Devon Jeffers,
Kamran Hussein,
Bruce Patterson
Posted: 26 February 2025
The Impact of Fentanyl and Morphine in Spinal Anesthesia for Cesarean Section on Maternal Hemodynamics
Ramona Celia Moisa,
Nicoleta Negrut,
Cezar Cristian Mihai Moisa,
Harrie Toms John,
Paula Marian
Posted: 25 February 2025
Intraoperative Ephedrine Use in Hip Arthroplasty: A Comparative Analysis of Spinal Anesthesia Combinations and Chronic Hypertensive Status
Erika Bimbo-Szuhai,
Mihai Octavian Botea,
Harrie Toms John,
Adela Bostan Danciu,
Pirvan Titus Razvan,
Mihaela Gabriela Bontea,
Caius Salajan,
Maria Viviana Rusu,
Adrian Gheorghe Osiceanu,
Iulia Codruta Macovei
Posted: 25 February 2025
Evaluating the Effectiveness of Perineural Nerve Block with Ropivacaine and Dexamethasone in Patients with Neurogenic Thoracic Outlet Syndrome – A Prospective Pilot Trial
Lucia Maria Winkler,
Christian Smolle,
Andreas Fellner,
Lars-Peter Kamolz,
Werner Girsch
Posted: 25 February 2025
Subcutaneous Lidocaine Infusion for Chronic Widespread Pain: A Chart Review and Survey Examining the Safety and Tolerability of Treatment
Nina Gregoire,
Kimberley Kaseweter,
Ethan Klukas,
Anita Sanan,
W. Francois Louw
Posted: 21 February 2025
A Retrospective Cohort Study on the Side Effects of Intrathecal Morphine Administration Combined with General Anaesthesia Versus General Anaesthesia Alone in Prostatectomy Patients
Timon Marvin Schnabel,
Hanaa Baagil,
Kim Karen Kutun,
Claus Eisenberger,
Mark Ulrich Gerbershagen
Posted: 21 February 2025
Opioid Analgesics: Rise and Fall of Ligand Biased Signalig and Future Perspectives in the Quest for the Holy Grail
Émile Breault,
Rebecca L. Brouillette,
Terence E. Hébert,
Philippe Sarret,
Élie Besserer-Offroy
Opioid analgesics have been used for more than 5,000 years and remain the main pain medications prescribed today. Although morphine is considered the gold standard of pain relief, this selective µ-opioid receptor (MOP) agonist provides only moderate relief for many chronic pain conditions, and produces a number of unwanted effects that can affect the patient’s quality-of-life, prevent adherence to treatment or lead to addiction. In addition to the lack of progress in developing better analgesics, there have been no significant breakthroughs to date in combating the above-mentioned side effects. Fortunately, a better understanding of opioid pharmacology has given renewed hope for the development of better and safer pain medications. In this review, we describe how clinically approved opioids were initially characterized as biased ligands and what impact this approach might have on clinical practice. We also looked at the preclinical and clinical development of biased MOP agonists, focusing on the history of oliceridine, the first specifically designed biased analgesic. In addition, we explore the discrepancies between ligands with low intrinsic efficacy and those with biased properties. Finally, we examine the rationale behind the development of biased ligands during the opioid crisis.
Opioid analgesics have been used for more than 5,000 years and remain the main pain medications prescribed today. Although morphine is considered the gold standard of pain relief, this selective µ-opioid receptor (MOP) agonist provides only moderate relief for many chronic pain conditions, and produces a number of unwanted effects that can affect the patient’s quality-of-life, prevent adherence to treatment or lead to addiction. In addition to the lack of progress in developing better analgesics, there have been no significant breakthroughs to date in combating the above-mentioned side effects. Fortunately, a better understanding of opioid pharmacology has given renewed hope for the development of better and safer pain medications. In this review, we describe how clinically approved opioids were initially characterized as biased ligands and what impact this approach might have on clinical practice. We also looked at the preclinical and clinical development of biased MOP agonists, focusing on the history of oliceridine, the first specifically designed biased analgesic. In addition, we explore the discrepancies between ligands with low intrinsic efficacy and those with biased properties. Finally, we examine the rationale behind the development of biased ligands during the opioid crisis.
Posted: 17 February 2025
Efficacy of Quadratus Lumborum Block for Postoperative Pain Management in Single-Port Total Laparoscopic Hysterectomy: A Randomized Observer-blinded Controlled Trial
Jihyun Chung,
Seunguk Bang,
Sangmook Lee,
Youngin Lee,
Hyun-Jung Shin,
Yoonji Park
Posted: 03 February 2025
Development of AI Model For Precision Anaesthesia Dosage Optimization
Oluwakemi E Aguda,
Samuel O Okodeh,
Abdulgafaar A Muslehat,
Ephraim O Nwoye
Posted: 03 February 2025
Genetic Variation and Sex-Based Differences: Current Considerations for Anesthetic Management
Stephen DiMaria,
Nicholas Mangano,
Adam Bruzzese,
Benjamin Bartula,
Shruti Parikh,
Ana Costa
Posted: 03 February 2025
Intrathecal Morphine in Major Abdominal and Thoracic Surgery: Observational Study
Silvia González Santos,
Antia Osorio López,
Borja Mugabure Bujedo,
Nuria González-Jorrín,
Alejandro Herreros Pomares,
Ane Abad-Motos,
Manuel Granell
Posted: 31 January 2025
Characterization of Sublingual Microvascular Tortuosity in Steady-State Physiology and Septic Shock
Athanasios Chalkias,
Nikolaos Papagiannakis,
Konstantina Katsifa,
Antonios Destounis,
Athanasios Gravos,
Sofia Kanakaki,
Georgios Karapiperis,
Faidra Koufaki,
Athanasios Prekates,
Paraskevi Tselioti
Posted: 27 January 2025
Is a Perioperative Opioid-Sparing Anesthesia-Analgesia Strategy Feasible in Open Thoracotomies? Findings from a Retrospective Matched Cohort Study
Vasileia Nyktari,
Georgios Stefanakis,
Georgios Papastratigakis,
Helen Diamantaki,
Emmanouela Koutoulaki,
Periklis Vasilos,
Giorgos Giannakakis,
Metaxia Bareka,
Alexandra Papaioannou
Background/Objectives: To assess the feasibility and effectiveness of a perioperative opioid-sparing anesthesia-analgesia (OSA-A) technique without regional nerve blocks compared to standard opi-oid-based technique (OBA-A) in open thoracotomies. Methods: This retrospective, propensi-ty-matched, case-control study was conducted at a university hospital from January 2017 to Feb-ruary 2021, including adult patients undergoing open thoracotomy for lung or pleura pathology. Sixty patients in the OSA-A group were matched with 40 in the OBA-A group. Outcomes included postoperative pain scores on days 0, 1, and 2; 24-hour postoperative morphine consumption; PACU and hospital length of stay; time to bowel movement; and rates of nausea and vomiting. Results: Of 120 eligible patients, 100 had complete records (60 OSA-A, 40 OBA-A). Demographics were similar, but ASA status scores were higher in the OBA-A group. The OSA-A group reported significantly lower pain levels at rest, during cough, and on movement on the first two postoperative days, shorter PACU stay, and required fewer opioids. They also had better gastrointestinal motility (p<0.0001) and lower rates of nausea and vomiting on postoperative days 1 and 2. A follow-up study with 68 patients (46 OSA-A, 22 OBA-A) assessing chronic pain prevalence found no signif-icant differences between the groups. Conclusions: OSA-A without regional nerve blocks for open thoracotomies is feasible and safe, improving postoperative pain management, reducing opioid consumption, shortening PACU stay, and enhancing early gastrointestinal recovery compared to OBA-A.
Background/Objectives: To assess the feasibility and effectiveness of a perioperative opioid-sparing anesthesia-analgesia (OSA-A) technique without regional nerve blocks compared to standard opi-oid-based technique (OBA-A) in open thoracotomies. Methods: This retrospective, propensi-ty-matched, case-control study was conducted at a university hospital from January 2017 to Feb-ruary 2021, including adult patients undergoing open thoracotomy for lung or pleura pathology. Sixty patients in the OSA-A group were matched with 40 in the OBA-A group. Outcomes included postoperative pain scores on days 0, 1, and 2; 24-hour postoperative morphine consumption; PACU and hospital length of stay; time to bowel movement; and rates of nausea and vomiting. Results: Of 120 eligible patients, 100 had complete records (60 OSA-A, 40 OBA-A). Demographics were similar, but ASA status scores were higher in the OBA-A group. The OSA-A group reported significantly lower pain levels at rest, during cough, and on movement on the first two postoperative days, shorter PACU stay, and required fewer opioids. They also had better gastrointestinal motility (p<0.0001) and lower rates of nausea and vomiting on postoperative days 1 and 2. A follow-up study with 68 patients (46 OSA-A, 22 OBA-A) assessing chronic pain prevalence found no signif-icant differences between the groups. Conclusions: OSA-A without regional nerve blocks for open thoracotomies is feasible and safe, improving postoperative pain management, reducing opioid consumption, shortening PACU stay, and enhancing early gastrointestinal recovery compared to OBA-A.
Posted: 27 January 2025
CLAIR Score: A Novel Risk Prediction Tool for Unmasking Unanticipated Difficult Airways
Chanatthee Kitsiripant,
Wilasinee Jitpakdee,
Maliwan Oofuvong,
Pannawit Benjawaleemas,
Nussara Dilokrattanaphichit,
Wipharat Juthasantikul,
Pannipa Phakam,
Qistina Yunuswangsa,
Polathep Vichitkunakorn
Posted: 23 January 2025
The Role of Cytokines in Perioperative Neurocognitive Disorders: A Review in the Context of Anesthetic Care
Hyun Jung Koh,
Jin Joo
Perioperative neurocognitive disorders (PNDs), including postoperative delirium, delayed neurocognitive recovery, and long-term postoperative neurocognitive disorders, present significant challenges for older patients undergoing surgery. Inflammation is a protective mechanism triggered in response to external pathogens or cellular damage. Historically, the central nervous system (CNS) was considered immunoprivileged due to the presence of the blood–brain barrier (BBB), which serves as a physical barrier preventing systemic inflammatory changes from influencing the CNS. However, aseptic surgical trauma is now recognized to induce localized inflammation at the surgical site, further exacerbated by the release of peripheral pro-inflammatory cytokines, which can compromise BBB integrity. This breakdown of the BBB facilitates the activation of microglia, initiating a cascade of neuroinflammatory responses that may contribute to the onset of PNDs. This review explores the mechanisms underlying neuroinflammation, with a particular focus on the pivotal role of cytokines in the pathogenesis of PND.
Perioperative neurocognitive disorders (PNDs), including postoperative delirium, delayed neurocognitive recovery, and long-term postoperative neurocognitive disorders, present significant challenges for older patients undergoing surgery. Inflammation is a protective mechanism triggered in response to external pathogens or cellular damage. Historically, the central nervous system (CNS) was considered immunoprivileged due to the presence of the blood–brain barrier (BBB), which serves as a physical barrier preventing systemic inflammatory changes from influencing the CNS. However, aseptic surgical trauma is now recognized to induce localized inflammation at the surgical site, further exacerbated by the release of peripheral pro-inflammatory cytokines, which can compromise BBB integrity. This breakdown of the BBB facilitates the activation of microglia, initiating a cascade of neuroinflammatory responses that may contribute to the onset of PNDs. This review explores the mechanisms underlying neuroinflammation, with a particular focus on the pivotal role of cytokines in the pathogenesis of PND.
Posted: 22 January 2025
Trends in Labor Analgesia: Analysis of Patients’ Web Searches Across Europe Using a Machine Learning Model
Matteo Luigi Giuseppe Leoni,
Martina Rekatsina,
Giustino Varrassi,
Marco Cascella,
Alberto Pasqualucci,
Pasquale Sansone,
Cristina Todde,
Annalisa Caruso,
Marco Mercieri
Epidural analgesia is widely regarded as the gold standard for pain relief during labor. Despite its effectiveness, significant disparities in adoption persist due to cultural, medical, and informational factors. This study aimed to analyze online search behaviors related to epidural analgesia in the six most populous European countries, evaluate temporal trends, and assess the predictive power of machine learning models for search volumes.MethodsWeekly search data from 2020 to 2024 were obtained from Google Trends for France, Germany, Italy, Spain, Turkey, and the United Kingdom (UK). Data were analyzed using linear regression, time-series decomposition, and Mann-Kendall tests to identify monotonic trends. An Auto Regressive Integrated Moving Average (ARIMA) model was developed to forecast search volumes for 2025. Machine learning models such as Random Forest (RF) and Gradient Boosting Machine (GBM), were employed to evaluate the influence of variables such as country and temporal factors on search patterns. Model performance was assessed using specific metric (R², RMSE, MAE, and MBE) and statistical comparisons were made between the models.ResultsFrance and Turkey exhibited significant downward trends in search interest, while Germany showed a slight upward trend, and Italy, Spain, and the UK demonstrated stable patterns. ARIMA forecast indicated stable search volumes for most countries, with the UK reaching the highest activity. RF outperformed GBM, achieving R² values of 0.92 (testing) and 0.93 (training), with "Country" identified as the most influential predictor. Associated queries highlighted common public concerns, including epidural timing, risks, and side effects.ConclusionsThese findings reveal the value of understanding public interest in epidural analgesia to address concerns effectively. Healthcare providers should guide patients toward reliable online information. Future initiatives should include educational tools, national health programs, and interdisciplinary collaboration to enhance informed decision-making and optimize maternal care outcomes.
Epidural analgesia is widely regarded as the gold standard for pain relief during labor. Despite its effectiveness, significant disparities in adoption persist due to cultural, medical, and informational factors. This study aimed to analyze online search behaviors related to epidural analgesia in the six most populous European countries, evaluate temporal trends, and assess the predictive power of machine learning models for search volumes.MethodsWeekly search data from 2020 to 2024 were obtained from Google Trends for France, Germany, Italy, Spain, Turkey, and the United Kingdom (UK). Data were analyzed using linear regression, time-series decomposition, and Mann-Kendall tests to identify monotonic trends. An Auto Regressive Integrated Moving Average (ARIMA) model was developed to forecast search volumes for 2025. Machine learning models such as Random Forest (RF) and Gradient Boosting Machine (GBM), were employed to evaluate the influence of variables such as country and temporal factors on search patterns. Model performance was assessed using specific metric (R², RMSE, MAE, and MBE) and statistical comparisons were made between the models.ResultsFrance and Turkey exhibited significant downward trends in search interest, while Germany showed a slight upward trend, and Italy, Spain, and the UK demonstrated stable patterns. ARIMA forecast indicated stable search volumes for most countries, with the UK reaching the highest activity. RF outperformed GBM, achieving R² values of 0.92 (testing) and 0.93 (training), with "Country" identified as the most influential predictor. Associated queries highlighted common public concerns, including epidural timing, risks, and side effects.ConclusionsThese findings reveal the value of understanding public interest in epidural analgesia to address concerns effectively. Healthcare providers should guide patients toward reliable online information. Future initiatives should include educational tools, national health programs, and interdisciplinary collaboration to enhance informed decision-making and optimize maternal care outcomes.
Posted: 07 January 2025
of 9